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The occurrence of urolithiasis in the United States has
increased; however, information on long-term trends,
including recurrence rates, is lacking. Here we describe
national trends in rates of emergency department visits, use
of imaging, and drug treatment, primarily using the National
Hospital Ambulatory Medical Care Survey to describe trends
and the National Health and Nutrition Examination Survey to
determine the frequency of lifetime passage of kidney stones.
Emergency department visit rates for urolithiasis increased
from 178 to 340 visits per 100,000 individuals from 1992 to
2009. Increases in visit rates were greater in women,
Caucasians, and in those aged 25–44 years. The use of
computed tomography in urolithiasis patients more than
tripled, from 21 to 71%. Medical expulsive therapy was used
in 14% of the patients with a urolithiasis diagnosis in
2007–2009. Among National Health and Nutrition
Examination Survey participants who reported a history of
kidney stones, 22.4% had passed three or more stones.
Hence, emergency department urolithiasis visit rates have
increased significantly, as has the use of computed
tomography in the United States. Further research is
necessary to determine whether recurrent stone formers
receive unnecessary radiation exposure during diagnostic
evaluation in the emergency department and allow
development of corresponding evidence-based guidelines.
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Urolithiasis is one of the most common urological diseases in
the United States.1 The lifetime risk of symptomatic kidney
stones isB13% in men and 7% in women.2,3 The prevalence
is highest in older white men and lowest in younger black
women.2–4 Studies suggest that kidney stone presentation also
varies by season and geographic region, with greater
frequency observed during the warmer months and in the
southern United States.4–7 Only limited information is
available on urolithiasis recurrence rates. The financial
burden of urolithiasis is substantial.8 Total annual medical
expenditures for urolithiasis in the United States exceeded $2
billion in 2000, and are expected to increase in the future.7
An important factor in the increased cost is the use of
medical imaging technology for the evaluation of urolithiasis
patients. However, there is also concern regarding the extent
of use of radiation in the evaluation of patients because of
potential adverse long-term sequelae, especially in patients
with recurrent disease and in younger patients.9
Although individuals with kidney stones may be asympto-
matic, many may experience severe pain from stone
passage.10 The prevalence and incidence of urolithiasis is
increasing globally11–14 and in the United States.2,15–17
However, reports of long-term trends in the occurrence of
urolithiasis in the United States are lacking. We examined
trends in diagnosis, use of imaging and drugs, and regional
and seasonal variation for urolithiasis in a nationally
representative sample of US emergency department (ED)
visits (National Hospital Ambulatory Medical Care Survey,
NHAMCS) over nearly a two-decade period beginning in the
early 1990s. We determined urolithiasis ED return visits using
the NHAMCS database and evaluated the number of
episodes of self-reported kidney stones among a nationally
representative sample of the population (National Health and
Nutrition Examination Survey, NHANES) to identify a
subgroup of patients who may receive unnecessary
radiation exposure from imaging during evaluation in the
ED for suspected urolithiasis.
The goals of this study were to assess secular trends in ED
urolithiasis visits, including imaging use in the United States,
and to estimate urolithiasis recurrence rates and return visits
in national and ED populations.
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RESULTS
Emergency department visit rates
A total of 551,577 ED visits were sampled from 1992 to 2009.
Upper tract urolithiasis was coded in 3403 visits. Accounting
for the sampling weights and complex sample design, over
this time, there were an estimated 12.45 million ED visits
(95% confidence interval (CI), 11.22–13.67 million) with a
diagnosis of upper tract urolithiasis, or about 700,000 visits
per year in the United States. These visits accounted for about
0.65% (95% CI, 0.61–0.69%) of all ED visits. To examine
temporal trends in urolithiasis, the number of ED visits with
a diagnosis code for urolithiasis was calculated as the average
annual ED visit rate. Among the entire U.S. noninstitutional
population, the rate of ED visits with a diagnostic code for
urolithiasis steadily increased from 178 (95% CI, 152–204)
per 100,000 individuals in the 1992–1994 survey period to
340 (95% CI, 284–395) per 100,000 individuals in the
2007–2009 survey period (Figure 1), an increase of 91%
(Ptrendo0.001). On the basis of a linear regression model by
fitting the first five visit rates from the 1992–1994 survey
period to the 2004–2006 survey period, we obtained a
projected increase of 27 ED visits per 100,000 individuals by
each 3-year period (rate¼ 147þ 27* period). Compared with
the predicted rate of 309 (95% CI, 280–337) for the
2007–2009 survey period, the observed rate of 340 (95%
CI, 284–395) corresponded to an excess increase of 31 ED
visits per 100,000 US population. However, the rate increase
in the last period was not significantly greater than the trend
seen in the previous surveys (P¼ 0.15).
Across all survey periods, ED visit rates for urolithiasis
were higher in men than women (Table 1). Although
urolithiasis ED visit rates increased in both genders from
the survey periods 1992–1994 to 2007–2009, the percentage of
increase in women (128%) was nearly twice that of men
(70%). In 1992–1994, the highest rate of ED visits for
urolithiasis was in individuals aged 45–64 years old. In all
subsequent surveys, the highest rate was in individuals aged
25–44 years old. The increase in ED urolithiasis visit rates in
each age group over the various surveys was statistically
significant, except for individuals 464 years of age. The
greatest increase (132%) was found in the 25–44 year age
group. The ED visit rate for urolithiasis among whites was
about twice that of non-whites for all survey periods except
2001–2003, where the white to non-white rate ratio was
nearly 3:1.
Although ED visit rates varied by season and by region of
the country, none of these differences were statistically
significant (Figure 2).
Use of imaging and drugs
The proportion of ED urolithiasis visits with any imaging
used increased from 56% (95% CI, 48–64%) in 1995–1997 to
79% (75–83%) in 2007–2009 (Ptrend¼ 0.015) (Table 2). The
percent of ED urolithiasis visits at which X-rays were ordered
decreased from 48% (95% CI, 40–55%) in 1995–1997 to 17%
(12–22%) in 2007–2009 (Ptrend¼ 0.005). In contrast, the use
of computed tomography (CT) increased from 21% (95% CI,
15–26%) in 1998–2000 to 71% of visits (65–77%) in
2007–2009 (Ptrend¼ 0.029). The frequency of the use of
ultrasound was low: 5–6% in the survey periods 2001–2003
and 2004–2006.
Among urolithiasis ED visits with any imaging, the
proportion of CT or X-ray/ultrasound use in the survey
periods 1998–2003 and 2004–2009 is shown in Figure 3.
In 1998–2003, approximately half the visits used CT,
increasing to 88% in 2004–2009. The use of CT increased
from 19% (95% CI, 11–27%) in 1998–2000 to 73% (65–80%)
in 2007–2009 in patients aged 25–44 years old (Ptrend¼ 0.018)
and from 42% (28–56%) in 2001–2003 to 64% (51–77%) in
patients o25 years in 2007–2009 (Ptrendo0.001) (Table 3).
The use of CT did not differ proportionally between men and
women with urolithiasis visits during any of the time periods
assessed, but increased in men (Ptrend¼ 0.028). The use of CT
did not differ proportionally between white and non-white
patients with urolithiasis visits during any of the time periods
assessed, but the proportion of use increased significantly in
white patients (Ptrend¼ 0.036).
The proportion of ED visits for codes indicating other
disorders of the urethra and urinary tract, symptoms
involving the urinary system, and other symptoms involving
the abdomen and pelvis with any imaging used increased
from 38% (95% CI, 35–40%) in 1995–1997 to 55% (53–57%)
in 2007–2009 (Ptrendo0.001). CT use in this group increased
from 2% (95% CI, 2–3%) in 1995–1997 to 30% (28–32%) in
2007–2009 (Ptrendo0.001) (data not shown).
Prescribed drugs were commonly used over the survey
periods (range 88–95%). Analgesic prescriptions increased
from 77% (95% CI, 73–81%) to 91% (89–94%)
(Ptrend¼ 0.022) of visits. Medical expulsive therapy (MET)
use was infrequent before 2007. In 2007–2009, MET was
prescribed in 14% (95% CI, 10–17%) of ED urolithiasis visits.
The mean number of prescribed drugs per ED urolithiasis
visit increased from 2.1 (95% CI, 1.9–2.2) in 1992–1994 to 3.4
(3.1–3.6) in 2007–2009 (Ptrend¼ 0.008).
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Figure 1 | Rates of visits per 100,000 US population with a
diagnosis of upper tract urolithiasis to US emergency
departments: 1992–2009. A weighted least-square regression
analysis showed a significant linear trend. Error bars are 95%
confidence intervals.
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Recurrence estimates
In the survey period 2001–2003, 5% (95% CI, 3–7%) of
urolithiasis ED visits were return visits, increasing to 10%
(7–13%) in the survey period 2007–2009.
A total of 528 NHANES 2007–2008 participants reported a
history of kidney stones. Among them, 22.4% (95% CI,
17.3–28.6%) reported that they had passed three or more
stones and 13.7% (9.7–19.0%) reported having passed four or
more stones.
These findings suggest that ED visits resulting in a
diagnosis of urolithiasis may include a substantial number
of individuals with recurrent episodes of kidney stones.
DISCUSSION
Over nearly 20 years beginning in the early 1990s, the rate of
ED visits with a diagnosis of upper tract urolithiasis in the
United States has steadily increased, nearly doubling from
178 to 340/100,000 population. In contrast, total ED visit
rates increased by only 16% over the same time period.18,19
Thus, the increase in ED urolithiasis visits was more than five
times greater than the proportional increase for all ED visits.
The greatest increases in ED urolithiasis visit rates occurred
among women, whites, and individuals aged 25–44 years old.
The use of all prescription drugs, including analgesics,
increased during the study period. The frequency of the use
of CT to aid in the diagnosis and management of urolithiasis
in the ED also increased significantly. Because the use of MET
began in 2007–2009, we are unable to report time trends.
Several recent US studies have also documented an
increase in the use of health-care resources7,20 and in the
incidence and prevalence15–17 of urolithiasis. In a study using
the NHAMCS, hospital outpatient urolithiasis visits
increased nationally by 40% between 1994 and 2000.7
Although we confirmed prior studies that show urolithiasis
to be more common in men, we found the percentage of
increase in ED visits to be nearly twice as great in women.
This finding is consistent with prior reports of an increase in
incident symptomatic stone disease15,21 and hospital
discharges for ureteral and renal calculi.22,23 In contrast, we
did not observe regional or seasonal differences in ED visit
rates for urolithiasis, using a large, comprehensive national
survey. However, the rates for both 9-year survey periods
were numerically highest in summer and in the South, in
agreement with several other studies.2,5,6
The increase in ED visits with urolithiasis diagnoses might
result from a combination of factors including an actual
change in disease incidence, improvement in diagnostic
methods, and/or an increase in the number of people who
use the ED for primary medical care. However, we cannot
identify the reasons for this increase from our data. We
believe the contribution of enhanced detection as a result of
improved imaging technology on the increase in urolithiasis
was likely modest, as several recent studies, using the
NHAMCS, have found that the increased use of CT was
not associated with a change in the proportion of diagnosis
of kidney stones among ED patients presenting with acute
flank or groin pain.20,24 Moreover, although we could not
exclude the possibility that more people with kidney stone
episodes use the ED for primary medical care, we would not
expect most of the increases observed in our study to be
because of this reason. Recent work suggests adults with
Medicaid accounted for most of the increase in ED visits
from 1997 to 2007 because of their increasing difficulties in
accessing primary care.25 As we could not envision that
patients with kidney stones are more likely to be Medicaid
recipients, and the increase in ED visits for urolithiasis was
much greater than the increase for all ED visits, our findings
are consistent with other reports of increased hospital
outpatient visits for urolithiasis.7
Because medical, lifestyle, or dietary information on
individual patients was not collected in NHAMCS, we can
only speculate on the reasons for the increased urolithiasis
rate. Over the period of the surveys, three important risk
factors for urolithiasis, obesity,26 diabetes,27 and the use of
Table 1 | Rates of emergency department visits with a diagnosis of upper tract urolithiasis by gender, age, and race: 1992–2009
1992–1994 1995–1997 1998–2000 2001–2003 2004–2006 2007–2009
No. Ratea 95% CI No. Ratea 95% CI No. Ratea 95% CI No. Ratea 95% CI No. Ratea 95% CI No. Ratea 95% CI
Percent
changeb Ptrend
c
Total 435 178 152, 204 326 190 158, 223 400 231 194, 268 731 263 226, 299 708 277 236, 317 803 340 284, 395 91 o0.001
Sex
Male 272 231 189, 274 198 240 193, 288 264 301 250, 351 437 331 275, 387 417 325 276, 374 441 393 322, 464 70 0.002
Female 163 127 99, 154 128 143 109, 176 136 165 127, 203 294 197 164, 231 291 230 187, 273 362 289 235, 343 128 o0.001
Age
o25 51 63 40, 86 39 72 44, 99 47 82 55, 110 77 73 49, 96 105 120 90, 150 101 112 83, 141 78 0.030
25–44 208 258 205, 310 168 303 237, 370 196 384 305, 462 340 444 368, 521 303 433 345, 521 366 599 472, 725 132 0.002
45–64 139 287 223, 350 83 240 175, 305 125 333 249, 416 258 367 299, 435 234 344 271, 417 275 431 345, 516 50 0.029
464 37 133 70, 197 36 169 95, 243 32 112 69, 154 56 176 120, 231 66 224 161, 288 61 216 138, 294 62 0.092
Race
White 391 191 163, 219 299 217 178, 256 354 252 211, 294 657 300 256, 344 629 309 263, 355 710 384 318, 450 101 o0.001
Non-white 44 112 61, 163 27 — — 46 134 84, 184 74 104 70, 138 79 145 98, 192 93 165 118, 213 47 0.21
Abbreviations: CI, confidence interval; No., unweighted visit number.
—: Data not shown have fewer than 30 records in the corresponding category. Estimates are considered unreliable.
aRate per 100,000 based on noninstitutional population estimates from National Hospital Ambulatory Medical Care Survey micro-data file documentation: 1992–2009.
bPercent change between 1992–1994 and 2007–2009.
cBased on weighted least squares regression analysis.
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dietary supplemental calcium28 have substantially increased
in the general population.29–32 Decreasing water intake33 and
other factors may also contribute to this increase in stone disease.
Future studies with patient-level information are needed to
identify specific risk factors for the increase in urolithiasis.
A prior report using NHAMCS data showed the use of CT
from 1996–1998 to 2005–2007 in patients presenting to the
ED with flank pain increased 10-fold.24 We also observed a
43-fold increase in the use of CT in urolithiasis patients over
the period 1998–2000 to 2007–2009.
The increased use of CT for evaluation of a common
clinical syndrome such as urolithiasis raises important
clinical questions. CT clearly provides important and
accurate diagnostic information for physicians caring for
patients with suspected urolithiasis. However, repeated use of
CT evaluations for patients with recurrent urolithiasis
contributes to increased radiation exposure for patients, as
well as an increase in costs. Several investigators have noted
that the potential burden of radiation exposure from medical
imaging is an important health issue, especially in younger
patients.9,20,24,34–39 Radiation reduction techniques, however,
may limit patient exposure.40–45 The findings from the
NHANES suggest that a significant percentage of all ED visits
with urolithiasis diagnoses may be because of patients with
recurrent stones. Data from the NHAMCS suggest that
return encounters comprise between 5 and 10% of ED
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Figure 2 | Rates of emergency department visits with a diagnosis
of upper tract urolithiasis by season and region, 1992–2009. (a)
Seasonal and (b) regional variation of emergency department visit
rates with a diagnosis of upper tract urolithiasis per 100,000
population from 1992–2000 to 2001–2009. Spring is March to May,
summer is June to August, fall is September to November, and winter
is December to February in this study. Error bars are 95% confidence
intervals.
Table 2 | Percentage of use of imaging and drugs at emergency department visits with a diagnosis of upper tract urolithiasis:
1992–2009
1992–1994 1995–1997 1998–2000 2001–2003 2004–2006 2007–2009
% 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI
Percent
changea Ptrend
b
Imaging use
Any imagingc NA NA 56 48, 64 55 49, 60 66 61, 71 78 74, 81 79 75, 83 41 0.015
X-ray NA NA 48 40, 55 34 28, 40 28 24, 32 21 17, 26 17 12, 22  65 0.005
Ultrasound NA NA — — — — 6 4, 8 5 3, 7 — —  17 NA
CT NA NA — — 21 15, 26 44 38, 49 65 60, 70 71 65, 77 238 0.029
Medication use
Visits with medication provided or prescribedd 88 84, 92 90 86, 95 89 85, 93 95 93, 97 95 93, 97 95 93, 97 8 0.020
Visits with analgesics provided or prescribede 77 73, 81 84 79, 90 82 78, 86 91 89, 94 90 87, 93 91 89, 94 18 0.022
Visits with MET provided or prescribed NA NA NA NA NA NA — — — — 14 10, 17 NA NA
Number of medications provided or prescribed (mean, 95% CI) 2.1 1.9, 2.2 2.4 2.2, 2.6 2.1 2.0, 2.3 2.8 2.7, 3.0 3.1 3.0, 3.3 3.4 3.1, 3.6 62 0.008
Abbreviations: CI, confidence interval; CT, computed tomography; MET, medical expulsive therapy; NA, not available.
—: Data not shown have fewer than 30 records or have a relative s.e. 430% in the corresponding category.
Estimates are considered unreliable.
aPercent change between 1995–1997 and 2007–2009 in any imaging and X-ray. Percent change between 2001–2003 and 2004–2006 in ultrasound. Percent change between
1998–2000 and 2007–2009 in CT. Percent change between 1992–1994 and 2007–2009 in medication use.
bBased on weighted least squares regression analysis.
cX-ray, ultrasound, or CT was ordered/provided at visit.
dVisits at which one or more medications were provided or prescribed.
eBased on National Drug Code directory (17XX) in 1992–2005 and Multum Lexicon second-level therapeutic drug category (058) in 2006–2009.
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Figure 3 | Percentage of computed tomography (CT) and X-ray/
ultrasound use in upper tract urolithiasis emergency department
visits with any imaging used from 1998–2003 to 2004–2009. Error
bars are 95% confidence intervals.
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urolithiasis visits. There are limited data regarding the
number of recurrent stone formers in the United States and
how frequently they visit emergency facilities.2,46 Goldstone
and Bushnell found that repeated CT imaging of patients
with recurrent nephrolithiasis resulted in a change in
diagnosis in only a small number of patients.47 The
estimate from NHANES of approximately one in seven
stone formers having four or more stone passages over the
lifespan suggests a lower limit for opportunities to avoid the
use of advanced radiologic imaging, thereby resulting in cost
savings and reducing radiation exposure.
The reasons for the increased use of advanced radiologic
evaluations in the ED for urolithiasis patients are unclear and
cannot be determined from the study database. They may
include increased sensitivity and specificity of CT evaluation
for urolithiasis, pressures related to fear of medical
malpractice claims, and patient demand.36,48 Physician time
pressures, increased reliance on technology, and use of
radiologic techniques as default measures for consultation
gateways and admission decisions may constitute incentives
to lower the threshold for use of such tests. Although CT
evaluation can locate a stone and assess hydronephrosis, the
clinical decision-making for a urolithiasis patient, especially a
recurrent stone former, in the absence of radiologic
assessment is often straightforward. After evaluation of
flank pain by physical examination and exclusion of other
causes of abdominal pain, urinalysis can suggest infection,
and hydration and provision of analgesics can be instituted.
This is especially true in patients with a history of
urolithiasis. If a stone is not passed during a follow-up
observation period, radiologic assessment can then proceed,
perhaps with an ultrasound. The proper balance between
traditional physical examination and use of advanced
radiologic techniques in patients with suspected urolithiasis
is uncertain, in part, because of the lack of evidence and
practice guidelines to inform clinical approaches for such
patients.49
We documented the use of MET by ED physicians
beginning in 2007, about the time when the management
guideline became available,49 observing a rate of 14%,
confirming prior reports of low MET use by ED
physicians.50,51 Education on the efficacy of MET for
urolithiasis among ED physicians may increase the use and
improve patient outcomes.52
This cross-sectional survey of ED encounters has several
limitations. The NHAMCS identifies ED visits and may
include multiple visits for a single patient. This is likely
minimized by the four-stage sampling design of the
NHAMCS in which a hospital is surveyed for B1 month
every 15 months. We did not have information regarding
factors that would account for increases in ED urolithiasis
diagnoses, nor for understanding the reasons for the
increased use of advanced imaging studies. We did not have
information about the location, size, or composition of
kidney stones, which limits our understanding of the clinical
characteristics of patients with urolithiasis ED visits.
As sample sizes in specific race/ethnicity categories were
small, evaluation of race/ethnicity was limited to the white
and non-white categories. Therefore, we were unable to assess
the burden of urolithiasis in Hispanic Americans, an
increasing segment of the US population, as well as in other
racial/ethnic groups. Validation of the accuracy of the codes
in the study was not determined by chart review. In addition,
we could not definitively determine whether the ED visit was
for new or recurring kidney stones.
In conclusion, over nearly the last 20 years, ED urolithiasis
visit rates increased substantially in the United States. Visit
rates increased disproportionately in women, whites, and in
individuals aged 25–44 years old. We could not demonstrate
seasonal or regional variation in ED visit rates for urolithiasis
over the study period. The relatively high rate of recurrent
kidney stone episodes and return ED visits for urolithiasis
patients in the population is consistent with the hypothesis
that such individuals presenting to the ED with flank pain
may receive unnecessary radiation exposure. These issues
need to be evaluated in appropriate, well-designed observa-
tional studies or randomized-controlled clinical trials.
Appropriate use of imaging guided by evidence is necessary
to minimize radiation exposure in individuals with suspected
urolithiasis who present to the ED.
MATERIALS AND METHODS
Data sources
We analyzed data from the ED component of the NHAMCS from
1992 to 2009. The NHAMCS identifies a nationally representative
Table 3 | Percentage of computed tomography use at
emergency department visits with a diagnosis of upper tract
urolithiasis, by selected characteristics: 1998–2009
1998–2000 2001–2003 2004–2006 2007–2009
% 95% CI % 95% CI % 95% CI % 95% CI Ptrend
a
Total 21 15, 26 44 38, 49 65 60, 70 71 65, 77 0.029
Age
o25 — — 42 28, 56 53 41, 65 64 51, 77 o0.001
25–44 19 11, 27 39 32, 47 64 57, 72 73 65, 80 0.018
45–64 — — 47 39, 55 71 62, 79 74 68, 80 0.24
464 — — — — 72 57, 86 60 45, 74 NA
P valueb NA 0.23 0.11 0.21
Sex
Female — — 44 37, 51 61 55, 68 68 60, 76 0.20
Male 24 16, 31 44 36, 51 68 62, 75 74 68, 79 0.028
P valueb NA 0.99 0.15 0.14
Race
White 21 15, 27 44 38, 50 65 60, 70 70 74, 76 0.036
Non-white — — 42 28, 57 66 52, 80 80 68, 92 0.10
P valueb NA 0.88 0.88 0.11
Abbreviations: CI, confidence interval; NA, not available.
—: Data not shown have fewer than 30 records or have a relative s.e. 430% in the
corresponding category.
Estimates are considered unreliable.
aBased on weighted least squares regression analysis.
bBased on Wald w2-tests.
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sample of visits to noninstitutional general and short-stay hospitals,
excluding Federal, military, and Veterans Administration hospitals,
located in 50 states and the District of Columbia. The survey was
approved by the Centers for Disease Control Institutional Review
Board, including a waiver of the requirement for informed consent
of sampled visits.
The survey uses a four-stage probability design with samples
of geographic areas, hospitals within these areas, EDs within
hospitals, and patient visits within EDs. The number of selected
hospitals with eligible EDs over the study period ranged from 379 in
2008 to 443 in 2003. The participation rate of sampled hospitals
over the study period varied from 89% in 2007 to 98% in 1998.53
Trained personnel at participating hospitals completed standardized
patient record forms for a systematic random sample of patient
visits during a randomly assigned 4-week period. The number of
forms collected in survey years varied from 21,103 in 1999 to 40,253
in 2003.53
Study population and variables
The NHAMCS permits recording of up to three physician diagnoses
per ED visit based on the International Classification of Diseases,
Ninth revision, Clinical Modification (ICD-9-CM). We identified all
visits with a code of 592.0 (calculus of kidney), 592.1 (calculus of
ureter), or 592.9 (urinary calculus, unspecified) as visits with upper
tract urolithiasis. Seventy-five percent of the visits had calculus of
kidney and ureter (592.x) as the primary diagnosis. Among the visits
with 592.x listed second or third, the most common accompanying
diagnoses were ‘other symptoms involving abdomen and pelvis’
(789.x; 37%), ‘symptoms involving urinary system’ (788.x; 24%),
and ‘other disorders of urethra and urinary tract’ (599.x; 15%). We
identified a secondary population, which included all visits with a
primary diagnostic code of 599.x, 788.x, or 789.x as a comparison
group.
We examined overall rates of ED visits with a diagnosis of upper
tract urolithiasis and rates according to gender, age (o25, 25–44,
45–64, and 464 years), race (white, non-white), season, and
by the geographic region in which the surveyed hospital was
located (Northeast, Midwest, South, and West). Months of the
year were grouped into seasons as follows: spring: March–May;
summer: June–August; fall: September–November; and winter:
December–February. Geographic regions are defined by the US
Bureau of the Census.53 The types of imaging for the diagnosis of
urolithiasis available from NHAMCS beginning in 1995 were plain
X-ray, abdominal ultrasound, and CT. In 2001–2004, the use of CT
and magnetic resonance imaging (MRI) was coded together. As MRI
is not generally used in the diagnostic evaluation of patients with
suspected urolithiasis,54 we assumed the combined CT/MRI results
represented CT use in 2001–2004. This approach was supported by
observing the same percentage of use of CT only and the CT/MRI
combined category in years in which CT and MRI were coded
separately (data not shown).
Medications administered or prescribed were coded for drug
class. As NHAMCS changed their coding system in 2006, we
identified analgesics using the National Drug Code categories (code
17xx) before 2006 and the Multum Lexicon second-level therapeutic
drug category (code 058) beginning in 2006 and thereafter. METwas
identified by the following generic drugs: alfuzosin, prazosin,
terazosin, doxazosin, silodosin, tamsulosin, and nifedipine. These
agents might also be prescribed for patients with hypertension or
benign prostatic hyperplasia. We cross-checked the concurrent
diagnoses of visits with MET and found only one visit with
urolithiasis and hypertension.
Estimate of lifetime stone passage and recurrence
We were unable to find reliable published information on the
frequency of recurrence of kidney stone episodes in the United
States to consider possible exposure of this subgroup of patients to
unnecessary radiation from imaging during evaluation for suspected
urolithiasis presenting in the ED. We analyzed data from the
NHANES 2007–2008, a nationally representative sample of the
noninstitutionalized population, to estimate the lifetime number of
kidney stones passed in the US adult population.55 The number
of stone passages was determined by the following question, asked
only of those individuals who answered affirmatively regarding
having ever had kidney stones: ‘‘How many times have you passed a
kidney stone?’’ Of 5935 sampled individuals aged 20 years and
older, 539 (9%) reported having had kidney stones. Eleven
participants were excluded from the analyses as they did not
provide an answer regarding the number of times they passed
kidney stones. A total of 528 participants were used to estimate
the number of lifetime stone passages. We set the following
categories for lifetime stone passages: 0–2 times or 42 times; 0–3
times or 43 times.
The item ‘episode of care (initial or follow-up visit to this ED for
problem)’ was available from NHAMCS beginning in 2001, but
unavailable in 2005 and 2006. Therefore, proportions of follow-up
visits (termed return visits) could only be reported in two study
periods (2001–2003 and 2007–2009). We used return visits as a proxy
for recurrence.
Data analysis
We used the weights and masked sample design variables of the
NHAMCS and NHANES, which were provided by the NCHS for
each record, to calculate the nationally representative point and
variance estimates for all analyses. The weight is an inflation factor
to estimate national counts. The sample design variables reflected
the complex multi-stage sample design of the surveys and were
intended for use with software such as SUDAAN that requires such
data for variance estimation.56 Details regarding the development of
the weights and sample design variables are described at the NCHS
website.53,56 Survey data in the NHAMCS were combined into
3-year groups to improve reliability of our estimates as follows:
1992–1994, 1995–1997, 1998–2000, 2001–2003, 2004–2006, and
2007–2009. Survey data were also combined into two 9-year groups,
1992–2000 and 2001–2009, to estimate ED visit rates for season and
geographic region. As reliable estimates of CT use were only
available from 1998 onward, two 6-year groups, 1998–2003 and
2004–2009, were used to present the percent change of using CT or
X-ray/ultrasound among ED visits with any imaging to aid in the
diagnosis of urolithiasis.
ED visit rates are reported as average annual rates for each 3-year
period (or 9-year period for season and region specific rate).
The rates were computed using the sum of the three (or nine) mid-
year total population estimates, or gender, age, race, and region-
specific population estimates from the US Census Bureau.53 All
rates were reported as number of visits per 100,000 U.S.
noninstitutional population. Visits in which imaging was used and
drugs for urolithiasis prescribed are expressed as percent of all visits
with a urolithiasis diagnosis code. Proportions were compared
across age, sex, and race groups using Wald w2-tests. Ninety-five
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percent CI for all rates and proportions were calculated. Trends in
the estimated visit rates and the temporal patterns of imaging and
drug use were analyzed using weighted least-squares regression
analyses. To test whether the rate in the 2007–2009 survey period was
significantly higher than what would be projected from the
preceding surveys, we created a linear regression model by fitting
the first five visit rates from the 1992–1994 survey period to the
2004–2006 survey period to obtain a predicted rate for the
2007–2009 survey period. The predicted and observed rates were
compared using the t-test.
All data management and analyses were performed using SAS
version 9.2 (SAS Institute, Cary, NC) and SAS callable SUDAAN
version 10.0.0 (Research Triangle Institute, Research Triangle
Park, NC). Two-sided P-valueso0.05 were considered statistically
significant.
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